NEWS
- Meet Us at TIDES USA 2025, Booth #913
- Top Blockbuster Drugs to Watch for in 2025
- FDA Approves Datroway (Datopotamab Deruxtecan) in HR+/HER2– Breast Cancer
- Good News! mPEG-pALD (20K) Successfully Completed The FDA DMF Filing
- 2024 FDA Approvals: 50 New Drugs
- FDA Approved PEGylated Drugs By 2025
- Diabetes & Weight Loss Drug Tirzepatide Now Approved for OSA (Obstructive Sleep Apnea)
- Small Nucleic Acid Drugs Expected to Be Approved by 2025
- FDA Approved First HER2/HER3 Bispecific Antibody - Zenocutuzumab (Bizengri)
- Celebrate Thanksgiving with 30% Off Monodispersed PEGs!